BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Amedica Corporation Names Distinguished Health Care Industry Executive Jay M. Moyes to Board of Directors


11/5/2012 12:35:47 PM

SALT LAKE CITY, Nov. 5, 2012 /PRNewswire/ -- Amedica Corporation, a spinal and reconstructive medical device manufacturer, announced today that esteemed financial executive Jay M. Moyes has been elected to its Board of Directors.

Mr. Moyes brings more than 30 years of management and leadership experience to the Amedica Board of Directors. He has been instrumental in the financial development and expansion of some of the medical industry's most groundbreaking companies including Myriad Genetics, where he guided the company through its initial public offering. Mr. Moyes currently sits on the Board of Directors with multiple biotechnology companies including Osiris Therapeutics Inc., Biocardia Inc., Integrated Diagnostics Inc., and Puma Biotechnology Inc. He formerly held a Board position with the Utah Life Science Industry Association.

"Jay brings a unique perspective to the Amedica leadership team. His experience and insight are incredibly valued as we work to further establish Amedica's position in the orthopedic industry," said Eric K. Olson, President and Chief Executive Officer, Amedica. "We look forward to drawing on the depth of his knowledge and business expertise as we expand our market penetration and continue developing innovative products that provide both clinical and economic value."

Throughout Mr. Moyes's career, he has worked with numerous industry-leading companies through their transformation from emerging growth to established, publicly-traded companies. Most recently, he served as Chief Financial Officer at XDX, an emerging molecular diagnostics company. Previously he served in the same role at Myriad Genetics, a publicly traded, leading biotechnology company focused on molecular diagnostics and therapeutic development. Prior to Myriad, Mr. Moyes served as Chief Financial Officer of Genmark, an agricultural biotechnology company, and as a Senior Manager with the international public accounting firm of KPMG. He holds a Masters in Business Administration from the University of Utah and received his undergraduate degree in economics from Weber State University.

About AMEDICA Corporation:

Amedica is an innovative spine and orthopaedic implant and device manufacturing and distribution company that provides advanced surgical applications including silicon nitride ceramic technologies. The company's platform technologies represent a new standard for implants and biologics based on superior performance, safety and efficacy. Amedica is a privately held, private equity backed company founded in 1996 by internationally recognized orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and sold in ten countries. Amedica Corporation is based in Salt Lake City, UT.

Media Contact
Stacey Holifield / Heather McIntyre
Schwartz MSL
(781) 684-0770
AMEDICA@schwartzmsl.com

SOURCE Amedica Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES